Recently, PRMT6 has been found to promote breast cancer metastasis through asymmetrical di-methylation of the signal transducer and activator of transcription 3 (STAT3), which activates downstream signaling in the IL-6/STAT3 pathway, contributing to tumor metastasis and invasion [264]. Here, STAT3 is linked to neoplasm.